Teratoma medical therapy
Teratoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Teratoma medical therapy On the Web |
American Roentgen Ray Society Images of Teratoma medical therapy |
Risk calculators and risk factors for Teratoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The mainstay of treatment for teratoma is surgical excision.The optimal therapy for teratoma depends on the stage at diagnosis. and also the type of teratoma Ovarian teratoma are chemosensitive
Medical Therapy
- Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].
- Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].
- Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
- Patients with ovarian teratoma are treated with chemotherapy as they are highly chemosensitive [1]whereas patients with [disease subclass 2] are treated with [therapy 2].
Disease Name
- 1 Stage 1 - Name of stage
- 1.1 Specific Organ system involved 1
- 1.1.1 Adult
- 1.1.2 Pediatric
- 1.1.2.1 (Specific population e.g. children < 8 years of age)
- 1.1.2.2 (Specific population e.g. 'children < 8 years of age')
- 1.2 Specific Organ system involved 2
- 1.1 Specific Organ system involved 1
- 2 Stage 2 - Name of stage
- 2.1 Specific Organ system involved 1
- Note (1):
- Note (2):
- Note (3):
- 2.1.1 Adult
- Parenteral regimen
- Oral regimen
- 2.1.2 Pediatric
- Parenteral regimen
- Preferred regimen (1): drug name 50–75 mg/kg IV q24h for 14 (14–21) days (maximum, 2 g)
- Alternative regimen (1): drug name 150–200 mg/kg/day IV q6–8h for 14 (14–21) days (maximum, 6 g per day)
- Alternative regimen (2): drug name 200,000–400,000 U/kg/day IV q4h for 14 (14–21) days (maximum, 18–24 million U per day) '(Contraindications/specific instructions)'
- Oral regimen
- Preferred regimen (2): drug name (for children aged ≥ 8 years) 4 mg/kg/day PO q12h for 14 (14–21) days (maximum, 100 mg per dose)
- Preferred regimen (3): drug name 30 mg/kg/day PO q12h for 14 (14–21) days (maximum, 500 mg per dose)
- Alternative regimen (1): drug name 10 mg/kg PO q6h 7–10 days (maximum, 500 mg per day)
- Parenteral regimen
- 2.2 'Other Organ system involved 2'
- Note (1):
- .2.1 Adult
- Parenteral regimen
- Oral regimen
- 2.2.2 Pediatric
- Parenteral regimen
- Preferred regimen (1): drug name 50–75 mg/kg IV q24h for 14 (14–21) days (maximum, 2 g)
- Alternative regimen (1): drug name 150–200 mg/kg/day IV q6–8h for 14 (14–21) days (maximum, 6 g per day)
- Alternative regimen (2): drug name 200,000–400,000 U/kg/day IV q4h for 14 (14–21) days (maximum, 18–24 million U per day)
- Parenteral regimen
- 2.1 Specific Organ system involved 1
References
- ↑ Douay-Hauser, Nathalie; Koskas, Martin; Walker, Francine; Luton, Dominique; Yazbeck, Chadi (2011). "Diagnosis and management of an immature teratoma during ovarian stimulation: a case report". Journal of Medical Case Reports. 5 (1). doi:10.1186/1752-1947-5-540. ISSN 1752-1947.